Many studies, which are mainly based on immunohistochemical and immunoblotting analysis, have demonstrated that FAK expression is increased in cancers of the thyroid, prostate, cervix, colon, rectum, oral epithelium, ovary and breast [28]–[36]. This evidence concerns the gene PTK2 and thyroid gland carcinoma.